Artigos de revistas sobre o tema "Atypical Chemokine Receptors"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Atypical Chemokine Receptors".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Hansell, C. A. H., C. V. Simpson e R. J. B. Nibbs. "Chemokine sequestration by atypical chemokine receptors". Biochemical Society Transactions 34, n.º 6 (25 de outubro de 2006): 1009–13. http://dx.doi.org/10.1042/bst0341009.
Texto completo da fonteBorroni, Elena M., Raffaella Bonecchi e Annalisa M. VanHook. "Science Signaling Podcast: 30 April 2013". Science Signaling 6, n.º 273 (30 de abril de 2013): pc11. http://dx.doi.org/10.1126/scisignal.2004231.
Texto completo da fonteGroblewska, Magdalena, Ala Litman-Zawadzka e Barbara Mroczko. "The Role of Selected Chemokines and Their Receptors in the Development of Gliomas". International Journal of Molecular Sciences 21, n.º 10 (24 de maio de 2020): 3704. http://dx.doi.org/10.3390/ijms21103704.
Texto completo da fonteUlvmar, Maria Helena, Elin Hub e Antal Rot. "Atypical chemokine receptors". Experimental Cell Research 317, n.º 5 (março de 2011): 556–68. http://dx.doi.org/10.1016/j.yexcr.2011.01.012.
Texto completo da fonteGencer, Selin, Emiel van der Vorst, Maria Aslani, Christian Weber, Yvonne Döring e Johan Duchene. "Atypical Chemokine Receptors in Cardiovascular Disease". Thrombosis and Haemostasis 119, n.º 04 (4 de fevereiro de 2019): 534–41. http://dx.doi.org/10.1055/s-0038-1676988.
Texto completo da fonteLegler, Daniel F., e Marcus Thelen. "New insights in chemokine signaling". F1000Research 7 (23 de janeiro de 2018): 95. http://dx.doi.org/10.12688/f1000research.13130.1.
Texto completo da fonteGustavsson, Martin, Douglas P. Dyer, Chunxia Zhao e Tracy M. Handel. "Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding". Science Signaling 12, n.º 598 (10 de setembro de 2019): eaaw3657. http://dx.doi.org/10.1126/scisignal.aaw3657.
Texto completo da fontePacheco, Messias Oliveira, Fernanda Agostini Rocha, Thiago Pinheiro Arrais Aloia e Luciana Cavalheiro Marti. "Evaluation of Atypical Chemokine Receptor Expression in T Cell Subsets". Cells 11, n.º 24 (16 de dezembro de 2022): 4099. http://dx.doi.org/10.3390/cells11244099.
Texto completo da fonteMiyabe, Yoshishige, Chie Miyabe, Vinidhra Mani, Thorsten R. Mempel e Andrew D. Luster. "Atypical complement receptor C5aR2 transports C5a to initiate neutrophil adhesion and inflammation". Science Immunology 4, n.º 35 (10 de maio de 2019): eaav5951. http://dx.doi.org/10.1126/sciimmunol.aav5951.
Texto completo da fonteLeick, Marion, Julie Catusse e Meike Burger. "The Atypical Chemokine Receptor CRAM Mediates CCL19 Transcytosis through Endothelial Cells and Modulates CCL19 Activation of Non-Hodgkin Lymphoma B Cells." Blood 114, n.º 22 (20 de novembro de 2009): 2672. http://dx.doi.org/10.1182/blood.v114.22.2672.2672.
Texto completo da fonteSamus, Maryna, e Antal Rot. "Atypical chemokine receptors in cancer". Cytokine 176 (abril de 2024): 156504. http://dx.doi.org/10.1016/j.cyto.2024.156504.
Texto completo da fonteChevigné, Andy, Bassam Janji, Max Meyrath, Nathan Reynders, Giulia D’Uonnolo, Tomasz Uchański, Malina Xiao et al. "CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6". Cancers 13, n.º 5 (2 de março de 2021): 1054. http://dx.doi.org/10.3390/cancers13051054.
Texto completo da fonteBlanchet, Xavier, Christian Weber e Philipp von Hundelshausen. "Chemokine Heteromers and Their Impact on Cellular Function—A Conceptual Framework". International Journal of Molecular Sciences 24, n.º 13 (30 de junho de 2023): 10925. http://dx.doi.org/10.3390/ijms241310925.
Texto completo da fonteBorroni, Elena M., Cinzia Cancellieri, Alessandro Vacchini, Yann Benureau, Bernard Lagane, Françoise Bachelerie, Fernando Arenzana-Seisdedos et al. "β-Arrestin–Dependent Activation of the Cofilin Pathway Is Required for the Scavenging Activity of the Atypical Chemokine Receptor D6". Science Signaling 6, n.º 273 (30 de abril de 2013): ra30. http://dx.doi.org/10.1126/scisignal.2003627.
Texto completo da fonteMelgrati, Serena, Egle Radice, Rafet Ameti, Elin Hub, Sylvia Thelen, Pawel Pelczar, David Jarrossay, Antal Rot e Marcus Thelen. "Atlas of the anatomical localization of atypical chemokine receptors in healthy mice". PLOS Biology 21, n.º 5 (9 de maio de 2023): e3002111. http://dx.doi.org/10.1371/journal.pbio.3002111.
Texto completo da fonteSchlecht-Louf, Géraldine, Claire Deback e Françoise Bachelerie. "The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy". Cancers 14, n.º 3 (8 de fevereiro de 2022): 848. http://dx.doi.org/10.3390/cancers14030848.
Texto completo da fontePatel, Manish, Iain McInnes e Gerard Graham. "Atypical Chemokine Receptors in Inflammatory Disease". Current Molecular Medicine 9, n.º 1 (1 de fevereiro de 2009): 86–93. http://dx.doi.org/10.2174/156652409787314480.
Texto completo da fonteSegerer, Stephan, Jan Jedlicka e Rudolf P. Wüthrich. "Atypical Chemokine Receptors in Renal Inflammation". Nephron Experimental Nephrology 115, n.º 4 (2010): e89-e95. http://dx.doi.org/10.1159/000313489.
Texto completo da fonteBachelerie, Françoise, Gerard J. Graham, Massimo Locati, Alberto Mantovani, Philip M. Murphy, Robert Nibbs, Antal Rot, Silvano Sozzani e Marcus Thelen. "New nomenclature for atypical chemokine receptors". Nature Immunology 15, n.º 3 (18 de fevereiro de 2014): 207–8. http://dx.doi.org/10.1038/ni.2812.
Texto completo da fonteNibbs, Robert J. B., e Gerard J. Graham. "Immune regulation by atypical chemokine receptors". Nature Reviews Immunology 13, n.º 11 (11 de outubro de 2013): 815–29. http://dx.doi.org/10.1038/nri3544.
Texto completo da fontePurvanov, Vladimir, Christoph Matti, Guerric P. B. Samson, Ilona Kindinger e Daniel F. Legler. "Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions". International Journal of Molecular Sciences 19, n.º 12 (4 de dezembro de 2018): 3876. http://dx.doi.org/10.3390/ijms19123876.
Texto completo da fonteCancellieri, Cinzia, Alessandro Vacchini, Massimo Locati, Raffaella Bonecchi e Elena M. Borroni. "Atypical chemokine receptors: from silence to sound". Biochemical Society Transactions 41, n.º 1 (29 de janeiro de 2013): 231–36. http://dx.doi.org/10.1042/bst20120246.
Texto completo da fonteTsou, Chia-Lin, Ron P. Gladue, Laurie A. Carroll, Tim Paradis, James G. Boyd, Robin T. Nelson, Kuldeep Neote e Israel F. Charo. "Identification of C-C Chemokine Receptor 1 (CCR1) as the Monocyte Hemofiltrate C-C Chemokine (HCC)-1 Receptor". Journal of Experimental Medicine 188, n.º 3 (3 de agosto de 1998): 603–8. http://dx.doi.org/10.1084/jem.188.3.603.
Texto completo da fonteMackie, Duncan I., Natalie R. Nielsen, Matthew Harris, Smriti Singh, Reema B. Davis, Danica Dy, Graham Ladds e Kathleen M. Caron. "RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis". Proceedings of the National Academy of Sciences 116, n.º 48 (11 de novembro de 2019): 24093–99. http://dx.doi.org/10.1073/pnas.1905561116.
Texto completo da fonteKhare, Tripti, Marc Bissonnette e Sharad Khare. "CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies". International Journal of Molecular Sciences 22, n.º 14 (9 de julho de 2021): 7371. http://dx.doi.org/10.3390/ijms22147371.
Texto completo da fonteLindsay, Hunter G., Colby J. Hendrix, Josue D. Gonzalez Murcia, Christopher Haynie e K. Scott Weber. "The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative Disorders". International Journal of Molecular Sciences 24, n.º 22 (18 de novembro de 2023): 16493. http://dx.doi.org/10.3390/ijms242216493.
Texto completo da fonteEller, Kathrin, e Alexander R. Rosenkranz. "Atypical chemokine receptors—“chemokine PACMANs” as new therapeutic targets in glomerulonephritis". Kidney International 93, n.º 4 (abril de 2018): 774–75. http://dx.doi.org/10.1016/j.kint.2017.12.021.
Texto completo da fonteDragan, Paulina, Matthew Merski, Szymon Wiśniewski, Swapnil Ganesh Sanmukh e Dorota Latek. "Chemokine Receptors—Structure-Based Virtual Screening Assisted by Machine Learning". Pharmaceutics 15, n.º 2 (3 de fevereiro de 2023): 516. http://dx.doi.org/10.3390/pharmaceutics15020516.
Texto completo da fonteBryce, Steven, Andrew Luster, Gerry Graham e Rob Nibbs. "The ‘atypical’ chemokine receptor CCRL1 aids dendritic cell migration from inflamed skin. (P6352)". Journal of Immunology 190, n.º 1_Supplement (1 de maio de 2013): 199.2. http://dx.doi.org/10.4049/jimmunol.190.supp.199.2.
Texto completo da fonteMassara, Matteo, Ornella Bonavita, Alberto Mantovani, Massimo Locati e Raffaella Bonecchi. "Atypical chemokine receptors in cancer: friends or foes?" Journal of Leukocyte Biology 99, n.º 6 (23 de fevereiro de 2016): 927–33. http://dx.doi.org/10.1189/jlb.3mr0915-431rr.
Texto completo da fonteLe Mercier, Alan, Remy Bonnavion, Weijia Yu, Mohamad Wessam Alnouri, Sophie Ramas, Yang Zhang, Yannick Jäger et al. "GPR182 is an endothelium-specific atypical chemokine receptor that maintains hematopoietic stem cell homeostasis". Proceedings of the National Academy of Sciences 118, n.º 17 (19 de abril de 2021): e2021596118. http://dx.doi.org/10.1073/pnas.2021596118.
Texto completo da fonteMartini, Rachel, Petros Nikolinakos, Jamie Hodgson, Brittany Jenkins e Melissa Davis. "The role of atypical chemokine receptor-1 in breast cancer immune response." Journal of Clinical Oncology 35, n.º 15_suppl (20 de maio de 2017): e23072-e23072. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e23072.
Texto completo da fonteGraham, G. J., M. Locati, A. Mantovani, A. Rot e M. Thelen. "The biochemistry and biology of the atypical chemokine receptors". Immunology Letters 145, n.º 1-2 (julho de 2012): 30–38. http://dx.doi.org/10.1016/j.imlet.2012.04.004.
Texto completo da fonteMajumdar, Shamik, Sergio M. Pontejo, Joseph Weaver e Philip M. Murphy. "Ackr1-deficient mice are protected from lethal SARS-CoV-2 challenge". Journal of Immunology 210, n.º 1_Supplement (1 de maio de 2023): 79.08. http://dx.doi.org/10.4049/jimmunol.210.supp.79.08.
Texto completo da fonteJohnsson, H., J. Cole, G. Wilson, M. Pingen, F. Mcmonagle, S. Holmes, I. Mcinnes, S. Siebert e G. Graham. "SAT0351 CHEMOKINE PATHWAYS ARE ENRICHED IN PSORIATIC ARTHRITIS (PSA) SKIN LESIONS WITH INCREASED EXPRESSION OF ATYPICAL CHEMOKINE RECEPTOR 2 (ACKR2)". Annals of the Rheumatic Diseases 79, Suppl 1 (junho de 2020): 1121.2–1122. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2980.
Texto completo da fonteDi Donato, Rachele, Raffaella Bonecchi e Francesca Albano. "Canonical and atypical chemokine receptors in the neutrophil life cycle". Cytokine 169 (setembro de 2023): 156297. http://dx.doi.org/10.1016/j.cyto.2023.156297.
Texto completo da fonteRusso, Remo C., Benedetta Savino, Massimiliano Mirolo, Chiara Buracchi, Giovanni Germano, Achille Anselmo, Luca Zammataro et al. "The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2+ and CCR5+ IFNγ-producing γδT cells in mice". American Journal of Physiology-Lung Cellular and Molecular Physiology 314, n.º 6 (1 de junho de 2018): L1010—L1025. http://dx.doi.org/10.1152/ajplung.00233.2017.
Texto completo da fonteSinitski, Dzmitry, Christos Kontos, Christine Krammer, Yaw Asare, Aphrodite Kapurniotu e Jürgen Bernhagen. "Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation". Thrombosis and Haemostasis 119, n.º 04 (4 de fevereiro de 2019): 553–66. http://dx.doi.org/10.1055/s-0039-1677803.
Texto completo da fonteCheng, Xiaoyun, e Mien-Chie Hung. "Regulation of Breast Cancer Metastasis by Atypical Chemokine Receptors: Fig. 1." Clinical Cancer Research 15, n.º 9 (21 de abril de 2009): 2951–53. http://dx.doi.org/10.1158/1078-0432.ccr-09-0141.
Texto completo da fonteDegroot, Gaetan-Nagim, Valentin Lepage, Marc Parmentier e Jean-Yves Springael. "The Atypical Chemerin Receptor GPR1 Displays Different Modes of Interaction with β-Arrestins in Humans and Mice with Important Consequences on Subcellular Localization and Trafficking". Cells 11, n.º 6 (18 de março de 2022): 1037. http://dx.doi.org/10.3390/cells11061037.
Texto completo da fonteTan, Wee Yee, Boon Yin Khoo e Ai Lan Chew. "Pichia-Expressed Recombinant D6 and DARC Negatively Affect Cell Migration and Invasion of Breast Cancer Cells". Sains Malaysiana 50, n.º 10 (31 de outubro de 2021): 3015–33. http://dx.doi.org/10.17576/jsm-2021-5010-15.
Texto completo da fontePan, Li, Jianliang Lv, Zhongwang Zhang e Yongguang Zhang. "Adaptation and Constraint in the Atypical Chemokine Receptor Family in Mammals". BioMed Research International 2018 (24 de setembro de 2018): 1–9. http://dx.doi.org/10.1155/2018/9065181.
Texto completo da fonteBurger, Nathalie, Andrea Haerzschel, Marion Leick, Tanja Nicole Hartmann, Julie Catusse e Meike Burger. "CCL19 Induced Responses Are Differentially Regulated by Atypical Chemokine Receptor CRAM and Its Classical Chemokine Receptor CCR7 in B-CLL Cells". Blood 118, n.º 21 (18 de novembro de 2011): 4896. http://dx.doi.org/10.1182/blood.v118.21.4896.4896.
Texto completo da fonteFord, Laura B., Vuk Cerovic, Simon W. F. Milling, Gerard J. Graham, Chris A. H. Hansell e Robert J. B. Nibbs. "Characterization of Conventional and Atypical Receptors for the Chemokine CCL2 on Mouse Leukocytes". Journal of Immunology 193, n.º 1 (2 de junho de 2014): 400–411. http://dx.doi.org/10.4049/jimmunol.1303236.
Texto completo da fonteCalvello, Rosa, Chiara Porro, Dario Domenico Lofrumento, Melania Ruggiero, Maria Antonietta Panaro e Antonia Cianciulli. "Decoy Receptors Regulation by Resveratrol in Lipopolysaccharide-Activated Microglia". Cells 12, n.º 5 (21 de fevereiro de 2023): 681. http://dx.doi.org/10.3390/cells12050681.
Texto completo da fonteKleist, Andrew B., Shawn Jenjak, Andrija Sente, Lauren J. Laskowski, Martyna Szpakowska, Maggie M. Calkins, Emilie I. Anderson et al. "Conformational selection guides β-arrestin recruitment at a biased G protein–coupled receptor". Science 377, n.º 6602 (8 de julho de 2022): 222–28. http://dx.doi.org/10.1126/science.abj4922.
Texto completo da fonteDobroch, Jakub, Klaudia Bojczuk, Adrian Kołakowski, Marta Baczewska e Paweł Knapp. "The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer". Molecules 27, n.º 7 (22 de março de 2022): 2041. http://dx.doi.org/10.3390/molecules27072041.
Texto completo da fontedel Molino del Barrio, Irene, Georgina Wilkins, Annette Meeson, Simi Ali e John Kirby. "Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12". International Journal of Molecular Sciences 19, n.º 11 (14 de novembro de 2018): 3592. http://dx.doi.org/10.3390/ijms19113592.
Texto completo da fonteBachelerie, Francoise, Adit Ben-Baruch, Amanda M. Burkhardt, Christophe Combadiere, Joshua M. Farber, Gerard J. Graham, Richard Horuk et al. "International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors". Pharmacological Reviews 66, n.º 1 (11 de novembro de 2013): 1–79. http://dx.doi.org/10.1124/pr.113.007724.
Texto completo da fonteKorbecki, Jan, Mateusz Bosiacki, Piotr Stasiak, Emilian Snarski, Agnieszka Brodowska, Dariusz Chlubek e Irena Baranowska-Bosiacka. "Clinical Aspects and Significance of β-Chemokines, γ-Chemokines, and δ-Chemokines in Molecular Cancer Processes in Acute Myeloid Leukemia (AML) and Myelodysplastic Neoplasms (MDS)". Cancers 16, n.º 19 (24 de setembro de 2024): 3246. http://dx.doi.org/10.3390/cancers16193246.
Texto completo da fonte